Global Tricuspid Valve Repair Market is expected to reach a US$2.5 billion market by 2028
Increasing geriatric population, growing preference for minimally invasive procedures like annuloplasty and transcathete…
Increasing geriatric population, growing preference for minimally invasive procedures like annuloplasty and transcathete…
BIOTRONIK, a leading manufacturer of cardio- and endovascular medical technology, announced today that patient enrollmen…
The BIOTRONIK Stent is the only Vascular Intervention Product Featured in this Year's ESC Hot Line Sessions. Late-bre…
BIOTRONIK announced today that the PK Papyrus covered coronary stent system has received CE mark for the treatment of ac…
BIOTRONIK Japan has announced enrollment of the first patient in the BIOFLOW-IV study, which aims to verify the efficacy…
BIOTRONIK, a leading manufacturer of innovative medical technology, has announced the market release of new 35 and 40 mm…
Primary end-point results from the BIOFLOW-II Clinical Study demonstrating the non-inferiority of the BIOTRONIK Orsiro H…
Oasmia and Abbott have entered into an exclusive global collaboration agreement with respect to Oasmia's two leading ani…
Diabetes, Bluthochdruck und Hypercholesterinämie waren wieder die Top 3 Indikationen basierend auf deren Gesamtumsatz 20…
. - Net sales of $274.3 million in line with QIAGEN's quarterly expectations, 8% organic net sales growth excluding swi…